"Bidi" Gram-negative bacteria identification and drug susceptibility test agent-4
Taiwan·Risk Class 2·BECTON, DICKINSON AND COMPANY (BD)·Registered Dec 19, 2005 – Dec 19, 2020Cancelled- Analysis ID
- 0cd0e048c0176247f1481885a897dbd5
- Customs Code
- DHA00601564409
- Manufacturer
- BECTON, DICKINSON AND COMPANY (BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- It is a rapid identification and susceptibility test for most aerobic and facultative anaerobic gram-negative bacteria from humans that have been selected for antibiotics.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
- Registration Date
- Dec 19, 2005
- Expiry Date
- Dec 19, 2020
- Cancellation Date
- Jun 07, 2022
- Status
- Logged out
- Reason
- 許可證已逾有效期
Access comprehensive regulatory information for "Bidi" Gram-negative bacteria identification and drug susceptibility test agent-4 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0cd0e048c0176247f1481885a897dbd5 and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.